DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Anuh Pharma Limited (ANUHPHR) share price today?

Anuh Pharma Limited (ANUHPHR) is trading at ₹82.89 on the NSE, down 1.00% on the day. Source: DocStoX.

What is the PE ratio of Anuh Pharma Limited?

Anuh Pharma Limited has a price-to-earnings (PE) ratio of 20.2 in the Healthcare sector.

What is the market capitalisation of Anuh Pharma Limited?

Anuh Pharma Limited has a market capitalisation of approximately ₹828 crore.

Is Anuh Pharma Limited a profitable company?

Anuh Pharma Limited generates a return on equity of 11.7% with a net profit margin of 5.3%. That is a modest return on shareholder capital.

What is the 52-week high and low of ANUHPHR?

Anuh Pharma Limited (ANUHPHR) has traded between ₹67 and ₹99.5 over the past 52 weeks, against a current price of ₹82.89.

Does Anuh Pharma Limited pay a dividend?

Yes. Anuh Pharma Limited currently offers a dividend yield of 1.64%. Dividend payments depend on the board's declaration each year.

ANUH Pharma Limited

₹82.89▼ -0.84 (-1.00%)

ANUHPHR·NSE·Healthcare

Market Cap

827.55 Cr

PE Ratio

20.22

Volume

53,342

Day High - Low

84.85 - 82.00

52W High-Low

99.50 - 67.00

₹82.89▼ -0.84 (-1.00%)

Market Cap827.55 Cr

PE Ratio20.22

Volume53,342

Day High - Low84.85 - 82.00

52W High-Low99.50 - 67.00

Anuh Pharma Limited (ANUHPHR): company summary

Annual revenue rose 16.6% to ₹772 crore, while annual net profit fell 12.7% to ₹41 crore.

Anuh Pharma Limited (ANUHPHR) is a micro-cap Healthcare company valued at ₹828 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Anuh Pharma Limited last traded at ₹82.89, modestly down 1.00% on the day.
Recent developments: On 2026-08-05, the company announced a dividend of ₹1.50 per share, with the ex-date set for the same day. The latest quarter results showed a significant improvement in net profit compared to the same quarter a year earlier.
Financial performance: Annual revenue rose 16.6% to ₹772 crore, while annual net profit fell 12.7% to ₹41 crore. The latest quarter saw revenue rise 4.2% year-on-year to ₹194 crore, and net profit surged 42.8% to ₹11 crore.
Valuation multiples: The stock trades at 20.2 times earnings, a discount to the Healthcare median of 32.0, 2.60 times book value. It yields 1.6%.
Things to watch: The net profit margin narrowed 1.8 percentage points to 5.3%. The company's return on equity fell to 11.7% from 7.1% in the prior year. The stock is 13.7% below its 52-week high.
Where it stands: The company's revenue growth outpaced profit growth, with net profit declining annually despite a strong performance in the latest quarter. The stock is trading 13.7% below its 52-week high, and the net profit margin has narrowed.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

5.0/10

Weak

Fair Value

ROE

11.65%

Average

P/E

20.22x

Fair

Debt / Equity

0.00

Low

Industry

Healthcare

Pharmaceuticals

Overall View

Weak

Price performance

Day₹82.00

₹84.85

52W₹67.00

₹99.50

DocStoX take

Supported by risk (8.0), but held back by valuation (3.8).

DocStoX score

Low confidence

5.0

/10

Weak

Quality

Modest

ROE 11.7%

Valuation

Rich

P/E 20.2×

Growth

Slow

Revenue +12.3% 5Y CAGR

Risk

Low risk

D/E 0.00

Momentum

Soft

49% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹83

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹828 Cr

52W High / Low

₹100 / ₹67

Dividend Yield

1.64%

Promoter Holding

71.80%

EPS (TTM)

₹4.10

Book Value

₹35.14

Key highlights

Low leverage — D/E 0.00
Profitable in all of the last 5 years
Small ₹828 cr company — thinner liquidity

2 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore ANUH PHARMA LIMITED’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

ANUH PHARMA LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

SUN PHARMACEUTICAL IND L DIVI S LABORATORIES LTD TORRENT PHARMACEUTICALS L APOLLO HOSPITALS ENTER. L ZYDUS LIFESCIENCES LTD LAURUS LABS LIMITED CIPLA LTD DR. REDDY S LABORATORIES AUROBINDO PHARMA LTD MANKIND PHARMA LIMITED LUPIN LIMITED MANIPAL HEALTH ENTERPRI L

Compare ANUH PHARMA LIMITED with peers

ANUH PHARMA LIMITED vs SUN PHARMACEUTICAL IND L ANUH PHARMA LIMITED vs DIVI S LABORATORIES LTD ANUH PHARMA LIMITED vs TORRENT PHARMACEUTICALS L ANUH PHARMA LIMITED vs APOLLO HOSPITALS ENTER. L ANUH PHARMA LIMITED vs ZYDUS LIFESCIENCES LTD ANUH PHARMA LIMITED vs LAURUS LABS LIMITED

Related tools & concepts

Value ANUH PHARMA LIMITED with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

ANUHPHR newsLatest coverage & filings Open screenerFilter the whole market